Market revenue in 2023 | USD 393.8 million |
Market revenue in 2030 | USD 661.8 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 50.03% in 2023. Horizon Databook has segmented the France interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
In France, the growing incidence & prevalence of Coronary Artery Disease (CAD) and improved screening measures for this disorder are driving the demand for innovative treatment options such as PTCA guidewires and coronary stents. These devices play a crucial role in reducing the risk of recurrent stroke in patients with certain cardiac conditions.
In France, the National Authority for Health (HAS) and the High Council for New Health Technologies (HCTN) provide recommendations on the reimbursement of medical devices, including interventional cardiology devices.
These recommendations are taken into account by the National Union of Health Insurance Funds (UNAM) and the National Federation of Mutual Health Insurance (FNS), which determine reimbursement rates for private health insurance providers.
Horizon Databook provides a detailed overview of country-level data and insights on the France interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into France interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account